 |
Devolux®
PLLA (Poly-L-Lactic Acid) is a biocompatible, biodegradable, high-molecular-weight synthetic polymer of L-lactic acid. PLLA-based injection fillers are widely used as long-lasting collagen stimulators. Devolux® PLLA filler is formulated for predictable collagen induction and tissue remodeling, making it an effective Poly-L-Lactic Acid PLLA injection filler option for facial rejuvenation and off-face applications.
PLLA is a resorbable filler class that has been shown in clinical practice to provide durable improvements; many clinical reports cite persistence of effect for extended periods (often up to around two years) depending on indication and individual response.
· Devolux — Low-price PLLA filler with robust collagen-stimulating properties.
· Devolux PLLA injections promote new collagen and elastin formation, firm and tighten skin, and help restore lost facial volume. For mature patients seeking structural restoration, Devolux PLLA is a suitable collagen stimulator.
· Dermax Devolux PLLA is produced to high quality standards and supplied with clear reconstitution guidance.
This methodology has evolved through clinical practice. Typical reconstitution and hydration practices commonly used are: 8–9 mL for face and 16 mL for off-face preparations, with a recommended hydration time of 24–72 hours prior to injection for optimal dispersion.
Forehead
Volume: 5-8ml
Injection level: blunt needles, flatly, mainly subcutaneously, supplemented by periosteum.
Remarks: Avoid excessive single-site volume to reduce risk of downward migration.
Temple
Volume: 2-3ml on one side
Injection level: blunt and sharp needles are used together. The levels are subcutaneous fat layer and temporal muscle layer.
Remarks: After injection, withdraw and apply uniform pressure to help even dispersion; then use a blunt cannula to feather PLLA across the subcutaneous plane.
Cheekbone
Volume: 2ml on one side
Injection level: It is recommended to use blunt needles flatly in multiple layers, subcutaneous, fat layer, fascia layer, subfascial tissue and periosteum.
Stretch marks
Mixing ratio: Add 15ml sterile water and 2ml Lidocaine.
Volume: 20ml-30ml
Injection level: Target the fractured dermal layer; for deeper lines insert sharp needles vertically into the deep dermis at affected sites.
Disclaimer: Please note that packaging designs may vary. Our products are intended for licensed medical professionals only. By purchasing, you agree to provide proof of credentials if requested. These medical devices are not for personal or home use. Please review all instructions carefully to understand contraindications and precautions.
PLLA (Poly-L-Lactic Acid) is a biocompatible, biodegradable, high-molecular-weight synthetic polymer of L-lactic acid. PLLA-based injection fillers are widely used as long-lasting collagen stimulators. Devolux® PLLA filler is formulated for predictable collagen induction and tissue remodeling, making it an effective Poly-L-Lactic Acid PLLA injection filler option for facial rejuvenation and off-face applications.
PLLA is a resorbable filler class that has been shown in clinical practice to provide durable improvements; many clinical reports cite persistence of effect for extended periods (often up to around two years) depending on indication and individual response.
· Devolux — Low-price PLLA filler with robust collagen-stimulating properties.
· Devolux PLLA injections promote new collagen and elastin formation, firm and tighten skin, and help restore lost facial volume. For mature patients seeking structural restoration, Devolux PLLA is a suitable collagen stimulator.
· Dermax Devolux PLLA is produced to high quality standards and supplied with clear reconstitution guidance.
This methodology has evolved through clinical practice. Typical reconstitution and hydration practices commonly used are: 8–9 mL for face and 16 mL for off-face preparations, with a recommended hydration time of 24–72 hours prior to injection for optimal dispersion.
Forehead
Volume: 5-8ml
Injection level: blunt needles, flatly, mainly subcutaneously, supplemented by periosteum.
Remarks: Avoid excessive single-site volume to reduce risk of downward migration.
Temple
Volume: 2-3ml on one side
Injection level: blunt and sharp needles are used together. The levels are subcutaneous fat layer and temporal muscle layer.
Remarks: After injection, withdraw and apply uniform pressure to help even dispersion; then use a blunt cannula to feather PLLA across the subcutaneous plane.
Cheekbone
Volume: 2ml on one side
Injection level: It is recommended to use blunt needles flatly in multiple layers, subcutaneous, fat layer, fascia layer, subfascial tissue and periosteum.
Stretch marks
Mixing ratio: Add 15ml sterile water and 2ml Lidocaine.
Volume: 20ml-30ml
Injection level: Target the fractured dermal layer; for deeper lines insert sharp needles vertically into the deep dermis at affected sites.
Disclaimer: Please note that packaging designs may vary. Our products are intended for licensed medical professionals only. By purchasing, you agree to provide proof of credentials if requested. These medical devices are not for personal or home use. Please review all instructions carefully to understand contraindications and precautions.
